All the Active Ingredient Drugs
Blood Coagulation Factor. Human Coagulation Factor II 200 – 480, Human Coagulation Factor VII 100 – 250, Human Coagulation Factor IX 200 – 310, Human Coagulation Factor X 220 – 600, Protein C 150 – 450, Protein S 120 – 380. VIAL: 1 + diluent. I.V. inject. Amount,
freq. as per individ. pt. basis. See lit.
Tmt., periop. prophylax. bleed. in
acquired defic. prothrombin complex
coagulat. factors, e.g., defic. due to tmt.
vit. K antagonists, or overdose of vit. K
antagonists, when rapid correct. of the
defic. required.
Blood Coagulation Factor. Human Coagulation Factor II 400 – 960, Human Coagulation Factor VII 200 – 500, Human Coagulation Factor IX 400 – 620, Human Coagulation Factor X 440 – 1200, Protein C 300 – 900, Protein S 240 – 760. VIAL: 1 + diluent. I.V. inject. Amount,
freq. as per individ. pt. basis. See lit.
Tmt., periop. prophylax. bleed. in
acquired defic. prothrombin complex
coagulat. factors, e.g., defic. due to tmt.
vit. K antagonists, or overdose of vit. K
antagonists, when rapid correct. of the
defic. required.
Human Coagulation Factor II 14 - 38 IU/ml, Human Coagulation Factor VII 9 - 24 IU/ml, Human Coagulation Factor IX 25 IU/ml, Human Coagulation Factor X 18 - 30 IU/ml, Protein C 13 - 31 IU/ml, Protein S 12 - 32 IU/ml. VIAL (pwdr. for sol. for inj.): 1 + solv.
See lit.
Tmt. bleed., periop. proph. bleed. in acq.
defic. prothrom. complex coag. factors,
such as defic. caused by tmt. with vit. K
antag./overdose vit. K antag. when rapid
correct. defic. req. Tmt. bleed periop.
proph. in congen. defic. vit. K depend.
coag. factors when purified specif. coag.
factor product not avail.
C/I: Hypersens. Known allergy to
heparin/history of heparin induced,
thrombocytopenia.